Politiparty
Politiparty

119th Congress Health

S. 641: Safe and Affordable Drugs from Canada Act of 2025

Introduced

  1. Introduced (completed)Feb 19, 2025
  2. Passed Senate (not reached)
  3. Passed House (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in Senate, Feb 19, 2025

This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.

Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.

An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs.

Read the full summary

The FDA must publish a list of approved Canadian pharmacies on its website.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

7

Bipartisan support.

Who scored on this bill

6 points earned
  1. 1Amy Klobuchar D-MN SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Amy Klobuchar

History

  1. Feb 19, 2025Introduced in the Senate by Amy Klobuchar.
Show the full action history (2 actions)
  1. Feb 19, 2025Introduced in Senate
  2. Feb 19, 2025Read twice and referred to the Committee on Health, Education, Labor, and Pensions.